1,678
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Consumer reporting of adverse events following immunization (AEFI)

Identifying predictors of reporting an AEFI

, , , &
Pages 747-754 | Received 18 Sep 2013, Accepted 08 Dec 2013, Published online: 09 Jan 2014

References

  • Aronson JK, Hauben M, Bate A. Defining ‘surveillance’ in drug safety. Drug Saf 2012; 35:347 - 57; http://dx.doi.org/10.2165/11597590-000000000-00000; PMID: 22462653
  • Griffin MR, Braun MM, Bart KJ. What should an ideal vaccine postlicensure safety system be?. Am J Public Health 2009; 99:Suppl 2 S345 - 50; http://dx.doi.org/10.2105/AJPH.2008.143081; PMID: 19797747
  • World Health Organisation. Global vaccine safety blueprint. Geneva, Switzerland: WHO, 2012.
  • Ellenberg SS, Braun MM. Monitoring the safety of vaccines: assessing the risks. Drug Saf 2002; 25:145 - 52; http://dx.doi.org/10.2165/00002018-200225030-00001; PMID: 11945111
  • Ellenberg SS, Chen RT. The complicated task of monitoring vaccine safety. Public Health Rep 1997; 112:10 - 20, discussion 21; PMID: 9018282
  • Wharton M. Vaccine safety: current systems and recent findings. Curr Opin Pediatr 2010; 22:88 - 93; http://dx.doi.org/10.1097/MOP.0b013e3283350425; PMID: 19952750
  • Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004; 23:287 - 94; http://dx.doi.org/10.1097/00006454-200404000-00002; PMID: 15071280
  • McNeil MM, Li R, Pickering S, Real TM, Smith PJ, Pemberton MR. Who is unlikely to report adverse events after vaccinations to the Vaccine Adverse Event Reporting System (VAERS)?. Vaccine 2013; 31:2673 - 9; http://dx.doi.org/10.1016/j.vaccine.2013.04.009; PMID: 23597717
  • Meranus D, Stergachis A, Arnold J, Duchin J. Assessing vaccine safety communication with healthcare providers in a large urban county. Pharmacoepidemiol Drug Saf 2012; 21:269 - 75; http://dx.doi.org/10.1002/pds.2245; PMID: 21956894
  • Parrella A, Braunack-Mayer A, Gold M, Marshall H, Baghurst P. Healthcare providers’ knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Serv Res 2013; 13:313; http://dx.doi.org/10.1186/1472-6963-13-313; PMID: 23945045
  • Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007; 63:148 - 56; http://dx.doi.org/10.1111/j.1365-2125.2006.02746.x; PMID: 17274788
  • Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, Hazell L, Krska J, Lee AJ, McLernon DJ, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. [iii-iv.] Health Technol Assess 2011; 15:1 - 234, iii-iv; PMID: 21545758
  • Waller PC. Making the most of spontaneous adverse drug reaction reporting. Basic Clin Pharmacol Toxicol 2006; 98:320 - 3; http://dx.doi.org/10.1111/j.1742-7843.2006.pto_286.x; PMID: 16611209
  • Borg JJ, Aislaitner G, Pirozynski M, Mifsud S. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Drug Saf 2011; 34:187 - 97; http://dx.doi.org/10.2165/11586620-000000000-00000; PMID: 21332243
  • Graham J. Magic number. The Australian Health Consumer, 2003:32-4.
  • NPS MedicineWise. Adverse Medicines Events Line. Available from: http://www.nps.org.au/contact-us/adverse-medicines-events
  • Australian Government Department of Health and Ageing TGA. Report an adverse event to a medicine. 2013. Available from: http://www.tga.gov.au/safety/problem.htm#medicine
  • Mahajan D, Cook J, Dey A, Macartney K, Menzies RI. Annual report: Surveillance of adverse events following immunisation in Australia, 2011. Commun Dis Intell Q Rep 2012; 36:E315 - 32; PMID: 23330706
  • Horvath J. Review of the management of adverse effects associated with Panvax and Fluvax. Canberra: Commonwealth of Australia 2011. Available from: http://www.health.gov.au/internet/immunise/publishing.nsf/Content/11DFBB4FD968D072CA25789400172DA1/$File/adverse-event-march-2011.pdf
  • Government of Western Australia DoH. 2012 Western Australian Vaccine Safety Surveillance Annual Report Disease Watch 2013. Available from: http://www.health.wa.gov.au/diseasewatch/vol17_issue1/wavss.cfm
  • Parrella A, Gold M, Marshall H, Braunack-Mayer A, Watson M, Baghurst P. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Hum Vaccin Immunother 2012; 8:662 - 7; http://dx.doi.org/10.4161/hv.19478; PMID: 22634441
  • Parrella A, Gold M, Marshall H, Braunack-Mayer A, Baghurst P. Parental perspectives of vaccine safety and experience of adverse events following immunisation. Vaccine 2013; 31:2067 - 74; http://dx.doi.org/10.1016/j.vaccine.2013.02.011; PMID: 23422146
  • Arnott J, Hesselgreaves H, Nunn AJ, Peak M, Pirmohamed M, Smyth RL, Turner MA, Young B. What can we learn from parents about enhancing participation in pharmacovigilance?. Br J Clin Pharmacol 2013; 75:1109 - 17; http://dx.doi.org/10.1111/j.1365-2125.2012.04441.x; PMID: 22905902
  • Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 2009; 32:1067 - 74; http://dx.doi.org/10.2165/11316680-000000000-00000; PMID: 19810778
  • Herxheimer A CM, Leonardo Alves T. Direct patient reporting of adverse drug reactions. A Twelve-Country Survey & Literature review. Paper Series Reference 01-2010/01, 2010.
  • van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf 2012; 35:45 - 60; http://dx.doi.org/10.2165/11594320-000000000-00000; PMID: 22149419
  • Durrieu G, Palmaro A, Pourcel L, Caillet C, Faucher A, Jacquet A, Ouaret S, Perault-Pochat MC, Kreft-Jais C, Castot A, et al, French Network of Pharmacovigilance Centres. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals. Drug Saf 2012; 35:845 - 54; http://dx.doi.org/10.1007/BF03261980; PMID: 22967189
  • Larson H, Brocard Paterson P, Erondu N. The globalization of risk and risk perception: why we need a new model of risk communication for vaccines. Drug Saf 2012; 35:1053 - 9; http://dx.doi.org/10.1007/BF03261991; PMID: 23061781
  • de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008; 31:515 - 24; http://dx.doi.org/10.2165/00002018-200831060-00006; PMID: 18484785
  • Ackerson BK, Sy LS, Yao JF, Craig Cheetham T, Espinosa-Rydman AM, Jones TL, Jacobsen SJ. Agreement between medical record and parent report for evaluation of childhood febrile seizures. Vaccine 2013; 31:2904 - 9; http://dx.doi.org/10.1016/j.vaccine.2013.03.073; PMID: 23583816
  • Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunizations? A national telephone survey. Pediatrics 2000; 106:1097 - 102; http://dx.doi.org/10.1542/peds.106.5.1097; PMID: 11061781
  • Kennedy A, Lavail K, Nowak G, Basket M, Landry S. Confidence about vaccines in the United States: understanding parents’ perceptions. Health Aff (Millwood) 2011; 30:1151 - 9; http://dx.doi.org/10.1377/hlthaff.2011.0396; PMID: 21653969
  • Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers’ influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 2006; 118:e1287 - 92; http://dx.doi.org/10.1542/peds.2006-0923; PMID: 17079529
  • Heininger U. An internet-based survey on parental attitudes towards immunization. Vaccine 2006; 24:6351 - 5; http://dx.doi.org/10.1016/j.vaccine.2006.05.029; PMID: 16784799
  • Robertson J, Newby DA. Low awareness of adverse drug reaction reporting systems: a consumer survey. Med J Aust 2013; 199:684 - 6; http://dx.doi.org/10.5694/mja13.10069; PMID: 24237099
  • Population Research and Outcomes Studies Unit. The health monitor survey methodology - 2002 -2012. Adelaide, 2002. Available from: http://health.adelaide.edu.au/pros/data/hm/
  • Berry JG, Gold MS, Ryan P, Duszynski KM, Braunack-Mayer AJ, Vaccine Assessment Using Linked Data (VALiD) Working Group. Public perspectives on consent for the linkage of data to evaluate vaccine safety. Vaccine 2012; 30:4167 - 74; http://dx.doi.org/10.1016/j.vaccine.2012.04.056; PMID: 22546331
  • Council for International Organizations of Medical Sciences. Definition and Application of Terms for Vaccine Pharmacovigilance. Report of CIOMS/WHO Working Group on Vaccine Pharmacovigilance. Geneva, 2012.
  • Long JSFJ. Regression models for categorical dependent variables using Stata. 2nd ed. College Station, TX: Stata Press; 2006. 527 p.
  • Australian Bureau of Statistics. Socio-Economic Indexes for Areas (SEIFA) - Technical Paper, 2006. Catalogue no. 2039.0.55.001. Canberra; 2008.
  • Australian Bureau of Statistics. Population estimates by age and sex, South Australia by Geographical Classification [ASGC 2009], 2004 and 2009 [Excel spreadsheet]. Catalogue no. 3235.0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.